000 | 01211 a2200349 4500 | ||
---|---|---|---|
005 | 20250518091211.0 | ||
264 | 0 | _c20200724 | |
008 | 202007s 0 0 eng d | ||
022 | _a1536-0229 | ||
024 | 7 |
_a10.1097/RLU.0000000000002977 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLópez-Mora, Diego Alfonso | |
245 | 0 | 0 |
_aThe Added Value of Tau-PET in the Assessment of Progressive Supranuclear Palsy. _h[electronic resource] |
260 |
_bClinical nuclear medicine _cMay 2020 |
||
300 |
_ae239-e240 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAminopyridines |
650 | 0 | 4 | _aFluorodeoxyglucose F18 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPositron-Emission Tomography |
650 | 0 | 4 | _aQuinolines |
650 | 0 | 4 |
_aSupranuclear Palsy, Progressive _xdiagnostic imaging |
650 | 0 | 4 |
_atau Proteins _xmetabolism |
700 | 1 | _aFernández León, Alejandro | |
700 | 1 | _aLleó, Alberto | |
700 | 1 | _aBlesa, Rafael | |
700 | 1 | _aCamacho, Valle | |
773 | 0 |
_tClinical nuclear medicine _gvol. 45 _gno. 5 _gp. e239-e240 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/RLU.0000000000002977 _zAvailable from publisher's website |
999 |
_c30720380 _d30720380 |